Searched for
GSK INDIA LAUNCHES
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- GSK India plans big 'reinvention', MD Bhushan Akshikar revealsGlaxoSmithKline Pharmaceuticals is planning a major comeback in India. The company aims to double its revenue to ₹8,000 crore within the ne...
- GSK re-enters India’s cancer drug marketGlaxoSmithKline Pharmaceuticals is re-entering India's oncology market with the launch of Jemperli and Zejula, precision therapies for gyna...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- GSK Pharma to expand into oncology, focus on adult vaccines in IndiaGlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and oncology in Indi...
- GSK India net profit grows 13% to Rs 131 crore in Q1FY24GlaxoSmithKline Pharmaceuticals (GSK India) on Wednesday reported 13% year-on-year (YoY) jump of net profit to Rs 131 crore for the quarter...
- GSK rolls out its Shingles vaccine in IndiaThe adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilita...
- GSK India appoints Bhushan Akshikar as managing directorAkshikar with over 26 years experience within the pharmaceutical industry, joined GSK India in September 2011 to lead the specialty and com...
- GSK launches global oral care brand Polident in IndiaDental experts and chemists will play a critical role in establishing the category in India, GSK said in the statement. “The company will w...
- Danone & Nestle launching a slew of new products in health and nutrition segmentWhile Nestle is re-launching Milo, Danone said it has nearly a dozen new products in its pipeline, like low sugar variants, bar and ready-t...
- ITC likely to be a strong contender to buy GSK's nutrition business including HorlicksNestle, Unilever, PepsiCo may look to buy its nutrition business, but ITC ‘likely strong contender’ as malt-based brands can expand its por...
- GSK Pharma's Bengaluru facility to be operational by 2017GSK India has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules ...
- Lack of health link blamed as GSK cans 4 products in new foods categoryLack of health link blamed as Horlicks maker withdraws 4 products in 2 years in newer food segments.
- GlaxoSmithKline Consumer Healthcare signs a brandsswap deal with GSK PharmaceuticalsThe cross-functional collaboration deal, to swap select brands and independently market, sell and distribute them, is one of the four lever...
- GSK Consumer: Will pushing Horlicks into new categories destroy the brand?In a radical departure from convention, GSK Consumer is pushing Horlicks, its superbrand, into new product categories. The strategy could b...
- ‘Productivity of global pharma R&D pipelines has fallen’The Indian arms of most global pharma giants have so far remained under-sized, rather off their parent’s radar for sometime now. But are th...
- Ranbaxy starts study on new respiratory inflammation medicineIndia's largest drugmaker Ranbaxy Laboratories has started initial clinical studies (Phase I) on the lead compound to develop a new respira...
- Glaxo, Ranbaxy expand R&D dealRanbaxy Laboratories announced on Tuesday the signing of a new multi-year R&D agreement with GlaxoSmithKline (GSK), which expands the terms...
- GSK on prowl, to get global productsThe pharma major is close to making key acquisitions in healthcare and OTC and launch new products.
Load More
